Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
VALUE CREATION, 50% Increase in Ordinary Profit, Record High for The First Time in Two Years, Dividend Raised by 0.5 yen
9238 VALUE CREATION CO.,LTD. 【J-GAAP】
Earnings ReportVALUE CREATION CO.,LTD. <9238> [TSE Growth] announced its financial results after the market closed on April 14th (15:30). The ordinary profit (non-consolidated) for the fiscal year ending February 2025 decreased 21.1% from the previous period to 131 million yen. In the fiscal year ending February 2026, the profit is expected to expand to 50.4% to 197 million yenExpected to reach record high profits for the first time in two years. This will be the seventh consecutive term of revenue growth.
At the same time, the company has decided to increase the dividend this fiscal year to 7 yen, an increase of 0.5 yen from the previous fiscal year.
In the most recent three-month period, from December to February (4Q), the ordinary profit surged 4.1 times that of the same period last year, reaching 73 million yen. The operating profit margin drastically improved from 0.9% in the same period last year to 7.0%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2024 | 2,948 | 172 | 166 | 114 | 55.1 | 6 | Apr 15, 2024 | J-GAAP |
Feb, 2025 | 3,431 | 121 | 131 | 86 | 37.5 | 6.50 | Apr 14, 2025 | J-GAAP |
YoY | +16.4% | -29.7% | -21.1% | -24.6% | -31.9% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2025 Guidance | 3,238 | 179 | 181 | 119 | 51.7 | 6.50 | Apr 15, 2024 | J-GAAP |
Feb, 2025 Results | 3,431 | 121 | 131 | 86 | 37.5 | 6.50 | Apr 14, 2025 | J-GAAP |
Revision Rate | +6.0% | -32.4% | -27.6% | -27.7% | -27.4% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Aug, 2024 | 1,782 | 56 | 51 | 29 | 12.8 | 0 | Oct 15, 2024 | J-GAAP |
Mar - Aug, 2025 Guidance | ー | ー | ー | ー | - | 0 | Apr 14, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2024 | 2,948 | 172 | 166 | 114 | 55.1 | 6 | Apr 15, 2024 | J-GAAP |
Feb, 2025 | 3,431 | 121 | 131 | 86 | 37.5 | 6.50 | Apr 14, 2025 | J-GAAP |
Feb, 2026 Guidance | 3,820 | 193 | 197 | 130 | 56.5 | 7 | Apr 14, 2025 | J-GAAP |
YoY | +11.3% | +59.5% | +50.4% | +51.2% | +50.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec - Feb, 2023 | 777 | 7 | 18 | 21 | 10.2 | 0.9 | Apr 15, 2024 | J-GAAP |
Mar - May, 2024 | 922 | 43 | 41 | 26 | 11.4 | 4.7 | Jul 12, 2024 | J-GAAP |
Jun - Aug, 2024 | 860 | 13 | 10 | 3 | 1.3 | 1.5 | Oct 15, 2024 | J-GAAP |
Sep - Nov, 2024 | 829 | 8 | 7 | 4 | 1.8 | 1.0 | Jan 14, 2025 | J-GAAP |
Dec - Feb, 2024 | 820 | 57 | 73 | 53 | 23.1 | 7.0 | Apr 14, 2025 | J-GAAP |
YoY | +5.5% | +714.3% | +305.6% | +152.4% | +128.0% |
Related Articles
FP Partner, Dec-Feb (1Q) Ordinary Profit Decreases by 42%
DIP, 10% Decrease in Ordinary Profit for The Current Fiscal Year
Totenko, 2% Increase in Ordinary Profit for The Current Fiscal Year
Asterisk, The Current Fiscal Year Ordinary Profit Revised Downward by 82%
Maruto Sangyo, 15% Increase in Ordinary Profit for The Current Fiscal Year
Daito Pharma, The Current Fiscal Year Ordinary Profit Revised Downward by 26%
KAWAKAMI PAINT, Dec-Feb (1Q) Ordinary Profit Turns to Loss
AFC-HD AMS Life Science, First Half Ordinary Profit Increases by 26%, Dec-Feb Ordinary Profit Increases by 10%
Life Foods, 52% Decrease in Ordinary Profit for The Current Fiscal Year, Resuming Dividends at 5 yen for the First Time in five terms., Plan to Continue the 5 yen Policy This Fiscal Year as Well
KAITORI OKOKU, 17% Increase in Ordinary Profit, Record High for The First Time in Two Years